Annual Current Assets
$124.23 M
-$7.26 M-5.52%
December 31, 2023
Summary
- As of February 8, 2025, AVTE annual total current assets is $124.23 million, with the most recent change of -$7.26 million (-5.52%) on December 31, 2023.
- During the last 3 years, AVTE annual current assets has risen by +$119.56 million (+2556.80%).
- AVTE annual current assets is now -28.74% below its all-time high of $174.33 million, reached on December 31, 2021.
Performance
AVTE Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$90.61 M
-$20.16 M-18.20%
September 30, 2024
Summary
- As of February 8, 2025, AVTE quarterly total current assets is $90.61 million, with the most recent change of -$20.16 million (-18.20%) on September 30, 2024.
- Over the past year, AVTE quarterly current assets has dropped by -$33.63 million (-27.07%).
- AVTE quarterly current assets is now -50.52% below its all-time high of $183.10 million, reached on September 30, 2021.
Performance
AVTE Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
AVTE Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -5.5% | -27.1% |
| 3 y3 years | +2556.8% | -27.1% |
| 5 y5 years | +3435.3% | -27.1% |
AVTE Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -28.7% | at low | -48.0% | at low |
| 5 y | 5-year | -28.7% | +3435.3% | -50.5% | +1837.7% |
| alltime | all time | -28.7% | +3435.3% | -50.5% | +1837.7% |
Aerovate Therapeutics Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $90.61 M(-18.2%) |
| Jun 2024 | - | $110.76 M(+7.3%) |
| Mar 2024 | - | $103.24 M(-16.9%) |
| Dec 2023 | $3.19 M(-16.3%) | $124.23 M(-9.7%) |
| Sep 2023 | - | $137.60 M(-9.8%) |
| Jun 2023 | - | $152.47 M(+26.5%) |
| Mar 2023 | - | $120.57 M(-8.3%) |
| Dec 2022 | $3.81 M | $131.50 M(-9.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $145.16 M(-5.4%) |
| Jun 2022 | - | $153.45 M(-7.5%) |
| Mar 2022 | - | $165.88 M(-4.8%) |
| Dec 2021 | $1.03 M(+2541.0%) | $174.33 M(-4.8%) |
| Sep 2021 | - | $183.10 M(+208.7%) |
| Jun 2021 | - | $59.31 M(+517.5%) |
| Mar 2021 | - | $9.60 M(+105.4%) |
| Dec 2020 | $39.00 K(>+9900.0%) | $4.68 M |
| Dec 2019 | $0.00 | - |
FAQ
- What is Aerovate Therapeutics annual total current assets?
- What is the all time high annual current assets for Aerovate Therapeutics?
- What is Aerovate Therapeutics annual current assets year-on-year change?
- What is Aerovate Therapeutics quarterly total current assets?
- What is the all time high quarterly current assets for Aerovate Therapeutics?
- What is Aerovate Therapeutics quarterly current assets year-on-year change?
What is Aerovate Therapeutics annual total current assets?
The current annual current assets of AVTE is $124.23 M
What is the all time high annual current assets for Aerovate Therapeutics?
Aerovate Therapeutics all-time high annual total current assets is $174.33 M
What is Aerovate Therapeutics annual current assets year-on-year change?
Over the past year, AVTE annual total current assets has changed by -$7.26 M (-5.52%)
What is Aerovate Therapeutics quarterly total current assets?
The current quarterly current assets of AVTE is $90.61 M
What is the all time high quarterly current assets for Aerovate Therapeutics?
Aerovate Therapeutics all-time high quarterly total current assets is $183.10 M
What is Aerovate Therapeutics quarterly current assets year-on-year change?
Over the past year, AVTE quarterly total current assets has changed by -$33.63 M (-27.07%)